Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Label, Post Marketing Study of the Safety and Effectiveness of HArmonyCa Injectable Gel for Mid-face Soft Tissue Augmentation

NCT05119777 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT05119777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Label, Post Marketing Study of the Safety and Effectiveness of HArmonyCa Injectable Gel for Mid-face Soft Tissue Augmentation
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
October 13, 2021
Completion date
September 15, 2023
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue augmentation